Helius (HSDT) Schedule 13G/A: Reporting Entities Report 0% Ownership
Rhea-AI Filing Summary
Helius Medical Technologies (HSDT) received a Schedule 13G/A filed by CVI Investments, Inc. and Heights Capital Management, Inc. The filers state they collectively hold 0 shares, representing 0% of the Class A common stock, and that ownership is at or below the 5% threshold. Heights Capital is identified as the investment manager to CVI and may be deemed to have voting and dispositive power over CVI's shares, while each party disclaims beneficial ownership except for any pecuniary interest.
The filing references a previously filed limited power of attorney and a joint filing agreement and contains no disclosure of an acquisition, disposition, or group control.
Positive
- Reporting persons disclose 0% ownership of Class A common stock, confirming no significant stake.
- Filing references a previously filed limited power of attorney and joint filing agreement, documenting the reporting relationship.
Negative
- None.
Insights
TL;DR: Routine ownership disclosure—reporting parties state zero holdings, so no material change to ownership or investor control.
The Schedule 13G/A confirms that CVI Investments and Heights Capital report 0% ownership of Helius Class A common stock, which is a clear, non-material disclosure for investors. The filing notes the manager-client relationship where Heights Capital serves as investment manager to CVI and may be deemed to have voting/dispositive power over shares owned by CVI, but both entities disclaim beneficial ownership except for pecuniary interest. No acquisition, >5% stake, or group control is reported.
TL;DR: Disclosure clarifies manager-client roles without indicating beneficial ownership or governance influence.
The document provides governance-related clarity: Heights Capital is identified as CVI's investment manager and a previously filed limited power of attorney and joint filing agreement are referenced. These filings document authority relationships but, per the statement, do not evidence beneficial ownership or an intent to influence control. From a governance perspective, this is a routine, neutral disclosure rather than a triggering event.
FAQ
Who filed the Schedule 13G/A for Helius (HSDT)?
Is the reported ownership above the 5% threshold for Helius (HSDT)?
Were any supporting documents or exhibits referenced?
AI-generated analysis. How Rhea-AI works. Not financial advice.